Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response

7 Apr 2021

Abstract excerpt

The treatment and management of patients with metastatic melanoma have evolved considerably in the "era" of personalized medicine. Melanoma was one of the first solid tumors to benefit from immunotherapy; life expectancy for patients in advanced stage of disease has improved. However, many progresses have yet to be made considering the (still) high number of patients who do not respond to therapies or who suffer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33917181
DOI: 10.3390/ijms22083837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy ResponsePMID 33917181Read ↗

Precision cancer medicine: the future is now, only better.Semantic proximity Read ↗

Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysisSemantic proximity Read ↗

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.Semantic proximity Read ↗

The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkersSemantic proximity Read ↗

Omics in Cutaneous Melanoma.Semantic proximity Read ↗

The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity Read ↗

Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches.Semantic proximity Read ↗

Pathways and therapeutic targets in melanoma.Semantic proximity Read ↗

Integrative Multi-Omics Analysis of Melanoma: Uncovering Pathways Associated with Immunotherapy OutcomesSemantic proximity Read ↗

Proteogenomics Reveals how Metastatic Melanoma Modulates the Immune System to Allow Immune EvasionSemantic proximity Read ↗

AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics BiomarkersSemantic proximity Read ↗

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.